A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies

por Muraro, Elena, Martorelli, Debora, Turchet, Elisa, Miolo, Gianmaria, Scalone, Simona, Comaro, Elisa, Talamini, Renato, Mastorci, Katy, Lombardi, Davide, Perin, Tiziana, Carbone, Antonino, Veronesi, Andrea, Crivellari, Diana, Dolcetti, Riccardo
Publicado 2011

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

por Miolo, Gianmaria, Muraro, Elena, Martorelli, Debora, Lombardi, Davide, Scalone, Simona, Spazzapan, Simon, Massarut, Samuele, Perin, Tiziana, Viel, Elda, Comaro, Elisa, Talamini, Renato, Bidoli, Ettore, Turchet, Elisa, Crivellari, Diana, Dolcetti, Riccardo
Publicado 2014